ArticleScientific reports2025

Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression.

Chia-Mu Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.